0000858581-23-000234.txt : 20230811 0000858581-23-000234.hdr.sgml : 20230811 20230811134407 ACCESSION NUMBER: 0000858581-23-000234 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230531 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 EFFECTIVENESS DATE: 20230811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T. Rowe Price Index Trust, Inc. CENTRAL INDEX KEY: 0000858581 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-05986 FILM NUMBER: 231162973 BUSINESS ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-345-2000 MAIL ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INDEX TRUST INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INSTITUTIONAL EQUITY FUNDS INC DATE OF NAME CHANGE: 19900227 0000858581 S000069930 T. Rowe Price U.S. Limited Duration TIPS Index Fund C000222750 T. Rowe Price U.S. Limited Duration TIPS Index Fund-Z Class TLDZX C000222751 T. Rowe Price U.S. Limited Duration TIPS Index Fund TLDTX C000222752 T. Rowe Price U.S. Limited Duration TIPS Index Fund-I Class TLDUX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000858581 XXXXXXXX false false N-1A S000069930 C000222751 C000222752 C000222750 T. ROWE PRICE INDEX TRUST, INC. 811-05986 0000858581 549300DT5TB0WREU3681 100 East Pratt Street Baltimore 21202 US-MD US 410-345-2000 JPMorgan Chase Bank London Woolgate House, Coleman Street London GB EC2P 2HD 0 44 20 7742 4000 Records related to the custody of Registrant s portfolio securities which are purchased outside the United States. State Street Corporation 1776 Heritage Drive Quincy 02171 617-786-3000 Custodian records for the Registrant. T. ROWE PRICE INDEX TRUST, INC. 100 East Pratt Street Baltimore 21202 410-345-2000 All accounts, books, and other documents required to be maintained by the Registrant under Section 31(a) of the Investment Company Act of 1940 and the rules thereunder. T. Rowe Price Services, Inc. 100 East Pratt Street Baltimore 21202 410-345-2000 Transfer, dividend disbursing, and shareholder service records The Bank of New York Mellon 103 Bellevue Parkway Wilmington 19809 1-800-441-9800 Fund accounting records N N N-1A 6 Y Bruce W. Duncan N/A N David Oestreicher 004594569 Y Eric L. Veiel 003269676 Y Kellye L. Walker N/A N Paul F. McBride N/A N Robert J. Gerrard, Jr. N/A N Teresa Bryce Bazemore N/A N Armando Capasso 007152939 100 East Pratt Street Baltimore 21202 XXXXXX N N N N N N T. Rowe Price Investment Services, Inc. 008-25130 000008348 N/A Y N PricewaterhouseCoopers LLP 238 5493002GVO7EO8RNNS37 N N N N N N N T. Rowe Price U.S. Limited Duration TIPS Index Fund S000069930 549300H9945456GGYS20 N 3 0 0 N N -0.90 -1.11 1.03 1.03 N N Y N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Revenue sharing split Other Rebate 0.00 11465.00 Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Section 12(d)(1)(G) of the Act (15 USC 80a-12(d)(1)(G)) Rule 18f-4 (17 CFR 270.18f-4) Rule 18f-4(f)(17 CFR 270.18f-4(f)) Y Y Y N T. Rowe Price Associates, Inc. 801-00856 000105496 7HTL8AEQSEDX602FBU63 N T. Rowe Price Retirement Plan Services, Inc. 084-01917 N/A Y Y T. Rowe Price Services, Inc. 084-01079 N/A Y N N Bloomberg Finance L.P. 5493001KJTIIGC8Y1R12 N ICE Data Services 13-3668779 Tax ID Number N Markit North America, Inc. N/A N Refinitiv US Holdings Inc. 549300NF240HXJO7N016 N N EUROCLEAR BANK SA/NV 549300OZ46BRLZ8Y6F65 BE N Y Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7) JPMorgan Chase Bank, London 7H6GLXDRUGQFU57RNE97 GB N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) JPMorgan Chase Bank, N.A. 7H6GLXDRUGQFU57RNE97 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) State Street Bank and Trust Company 571474TGEMMWANRLN572 N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N T. Rowe Price Retirement Plan Services, Inc. N/A N/A Y Y T. Rowe Price Services, Inc. N/A N/A Y N N T. Rowe Price Associates, Inc. 7HTL8AEQSEDX602FBU63 N/A Y N N T. Rowe Price Investment Services, Inc. 008-25130 000008348 N/A 0.00 BOFA SECURITIES, INC. 008-69787 000283942 549300HN4UKV1E2R3U73 1080.00 Citigroup Inc. N/A N/A 6SHGI4ZSSLCXXQSBB395 37882.00 GOLDMAN SACHS & CO. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 65383.00 J.P. MORGAN SECURITIES LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 59216.00 MORGAN STANLEY & CO. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 36459.00 200021.00 BARCLAYS CAPITAL INC. 008-41342 000019714 AC28XWWI3WIBK2824319 311852150.00 BMO Capital Markets Corp. N/A N/A NQQ6HPCNCCU6TUTQYE16 CA 322182447.00 CITADEL SECURITIES INSTITUTIONAL LLC 008-69663 000281102 549300MLQ1S3715IUK04 402383708.00 Citigroup Inc. N/A N/A 6SHGI4ZSSLCXXQSBB395 849613483.00 Deutsche Bank Aktiengesellschaft N/A N/A 7LTWFZYICNSX8D621K86 DE 664757622.00 GOLDMAN SACHS & CO. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 288962473.00 J.P. MORGAN SECURITIES LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 506344048.00 MORGAN STANLEY & CO. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 515056674.00 UBS AG N/A N/A BFM8T61CT2L1QCEMIK50 CH 308810164.00 WELLS FARGO SECURITIES, LLC 008-65876 000126292 VYVVCKR63DVZZN70PB21 193299513.00 5063058082.00 N 1524141337.00 N N N N true INTERNAL CONTROL RPT 2 g1aiii_trp_indextrust.htm

 

 

Report of Independent Registered Public Accounting Firm

 

To the Board of Directors of T. Rowe Price Index Trust, Inc. and Shareholders of T. Rowe Price U.S. Limited Duration TIPS Index Fund

 

In planning and performing our audit of the financial statements of T. Rowe Price U.S. Limited Duration TIPS Index Fund (one of the funds constituting T. Rowe Price Index Trust, Inc., hereafter collectively referred to as the “Funds”) as of and for the year ended May 31, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds’ internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Funds’ internal control over financial reporting.

 

The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

PricewaterhouseCoopers LLP, 100 East Pratt Street, Suite 2600, Baltimore, Maryland 21202-1096
T: 410 783 7600, www.pwc.com/us

 

 

 

 

 

Our consideration of the Funds’ internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds’ internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of May 31, 2023.

 

This report is intended solely for the information and use of the Board of Directors of T. Rowe Price Index Trust, Inc. and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

 

/s/ PricewaterhouseCoopers LLP

 

Baltimore, Maryland 

July 20, 2023

 

2